Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY:LLY)

769.88 +4.20 (+0.55%)
Official Closing Price Updated: 7:00 PM EDT, Jun 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
99 100 Next >
Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Popped Today
Pfizer bows, but is not entirely out of the GLP-1 race. 
Via The Motley Fool
What's Going On With Viking Therapeutics, Structure Therapeutics Stock On Monday?
Pfizer ends danuglipron development after liver safety issue, boosting shares of Viking, Eli Lilly, and Novo Nordisk amid obesity drug competition. 
Via Benzinga
Eli Lilly Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)
Via Benzinga
Pfizer Ends Development Of Weight Loss Pill Due To Potential Drug-Induced Liver Injury In A Patient
According to Pfizer, the reported patient’s liver enzymes “recovered rapidly” after they stopped taking the company’s experimental weight loss pill. 
Via Stocktwits
Topics Government
Exposures Political
Pfizer Scraps Obesity Pill After Potential Drug-Tied Liver Injury
The company is continuing to test a daily pill that blocks GIPR. 
Via Investor's Business Daily
Investing $60,000 in These 3 Funds Could Generate Annual Income of Over $6,500
Via The Motley Fool
Novartis Commits $23 Billion To Expand US Manufacturing Over Five Years, Despite Tariffs Uncertainties
Novartis commits $23 billion to expand U.S. manufacturing and R&D with 10 new facilities, aiming to produce all key U.S. medicines domestically and add thousands of jobs. 
Via Benzinga
3 Value Stocks in the Doghouse
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are... 
Via StockStory
Building Wealth Through Economics: A Patriotic Investor’s Guide To Tariffs 2.0 And Why
Massive container ports and supply chains worldwide are bracing for impact as broad U.S. import tariffs reshape commerce. 
Via Talk Markets
Topics ETFs Stocks / Equities World Trade
Exposures Tariff
Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies
Even as Donald Trump paused the reciprocal tariffs for 90 days, he later confirmed that pharmaceutical companies would face tariffs. 
Via Benzinga
Topics Government World Trade
Exposures Political Tariff
China Deal Is 'Going To Work Out,' Trump Says As Stocks Bounce From Session Lows
Wall Street trimmed steep losses in afternoon trading Thursday, following remarks from President Donald Trump, who expressed some optimism about reaching trade agreements, particularly with China. 
Via Benzinga
Topics Government
Exposures Political
Select Medical, Phreesia, Eli Lilly, Pfizer, and Brink's Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after stocks gave back some of the gains from the previous day as the White House clarified the tariffs on imports from China would add up to 145%,... 
Via StockStory
Topics Economy Government World Trade
Exposures Economy Political Tariff
Trump Wants RFK Jr. To 'Go Wild' On Health Care. What This Means For Biotech Stocks.
From vaccines to fluoride and beef tallow, here's where Robert F. Kennedy Jr. is making changes to health care. 
Via Investor's Business Daily
Topics Government
Exposures Political Product Safety
Behind the Scenes of Eli Lilly's Latest Options Trends
Via Benzinga
Dexcom Surges After FDA Clears Its Next-Generation Diabetes Device
Dexcom stock surged Thursday after the FDA cleared its newest diabetes device for an extended 15-day wear time. 
Via Investor's Business Daily
Topics Government Stocks World Trade
Exposures Political Product Safety Tariff
Hims’ Weight Loss Expansion: Real Growth or Just Hype?
Will Hims and Hers' addition of Eli Lilly's Zepbound to its weight loss platform be a big new growth driver? Or, is this development all bark and no bite? 
Via MarketBeat
Exposures Product Safety
Q4 Earnings Highs And Lows: Eli Lilly (NYSE:LLY) Vs The Rest Of The Branded Pharmaceuticals Stocks
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Eli Lilly (NYSE:LLY) and its peers. 
Via StockStory
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
Pharma Industry Faces Jitters As Trump Hints At Historic Tariffs, BofA Outlines Probable Timeline
Trump hints at major tariffs on foreign pharmaceuticals, sparking concerns for Indian suppliers and potential hikes in U.S. drug costs. 
Via Benzinga
Topics Government Supply Chain World Trade
Exposures Political Supply Chain Tariff
What's going on in today's session: S&P500 movers
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Wednesday. 
Via Chartmill
Why Roche Holding, Eli Lilly, and AstraZeneca Stocks Dropped Today
Might the tariff risk for pharmaceutical stocks be less than you think? 
Via The Motley Fool
Topics Government World Trade
Exposures Political Tariff
Eli Lilly CEO David Ricks Just Delivered Terrible News to Investors: Should You Sell the Stock?
Via The Motley Fool
Topics Economy Government World Trade
Exposures Economy Political Tariff
5 Top Growth Stocks to Buy in the Stock Market Sell-Off
Via The Motley Fool
Topics Government
Exposures Political
Dow Jones, S&P 500 Pharma Names Slammed As New Trump Tariffs Target Drug Imports
Big pharmaceutical names plowed lower Wednesday after Trump on Tuesday said that tariffs would take aim at drug imports. 
Via Investor's Business Daily
Topics Government Stocks World Trade
Exposures Political Tariff US Equities
Trump Hints At 'Major Tariff' On Imported Pharmaceuticals: Pfizer, Eli Lilly, Amgen And Other Stocks Tumble In Wednesday Pre-Market
President Donald Trump has declared that his administration is on the brink of imposing a significant tariff on pharmaceuticals imported from foreign countries. 
Via Benzinga
Topics Government World Trade
Exposures Political Tariff
Dr. Oz Officially Confirmed as Head of the Centers for Medicare and Medicaid Services. Here's What Retirees Need to Know So Far.
Via The Motley Fool
Topics Government
Exposures Political
3 Unstoppable Stocks That You Can Buy and Hold for Years
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
As Trump Tariffs Spark Panic, Investors Rush Into These 5 'Recession-Proof' ETFs
ETFs that provide exposure to sectors that have historically been considered defensive during downturns are now in the limelight. 
Via Benzinga
Topics ETFs Government
Exposures Political
Trump Administration Reverses Biden's Plan For Medicare Coverage Of Obesity Drugs Like Ozempic And Zepbound
CMS finalizes 2026 Medicare Advantage updates while halting proposed anti-obesity drug coverage, impacting millions of potential beneficiaries. 
Via Benzinga
Topics Government
Exposures Political
CVS Health Appoints New CFO, Chief Medical Officer: Retail Sentiment Soars
The company said that Brian Newman has been named chief financial officer, effective April 21, succeeding current CFO Tom Cowhey. 
Via Stocktwits
Blackstone Stock Gets Price Target Cuts From Citi, Barclays, Piper Sandler — Retail Remains Bearish
Citi analyst Christopher Allen lowered the firm's price target on Blackstone to $137 from $190 and kept a ‘Neutral' rating on the shares. 
Via Stocktwits
Topics Economy Government World Trade
Exposures Economy Political Tariff
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.